To examine associations between adiposity and adiposity change (loss, stable, gain) and subsequent longitudinal cognitive performance in African Americans in mid and late life. DESIGN: Cohort study using linear mixed models. SETTING: Genetic Epidemiology Network of Arteriopathy. PARTICIPANTS: African-American sibships with hypertension in Jackson, Mississippi (N = 1,108). MEASUREMENTS: Waist circumference and body mass index (BMI) were measured at two examinations 5 years apart. Stable adiposity was defined as values within 5% of the first measure. A composite cognitive Z-score was derived from individual cognitive test Z-scores at two study visits 6 years apart. RESULTS: Larger waist circumference was associated with greater rate of cognitive decline during follow-up (beta = À0.0009 per year, P = .001); BMI, change in waist circumference, and change in BMI were not associated with rate of decline. Loss of adiposity in midlife was associated with higher cognitive Z-scores in middle-aged individuals, and loss of adiposity in late life was associated with lower Z-scores in older adults (P = .01 for interaction between waist circumference and age; P = .04 for interaction between BMI and age). Simultaneous inclusion of waist circumference and BMI in the cross-sectional model suggested an association between larger waist circumference and poorer cognitive performance (beta = À0.009, P = .006) and between higher BMI and better cognitive performance (beta = 0.014, P = .06). CONCLUSION: The results suggested a differential pattern of the relationship between adiposity and cognition according to age (mid-or late life) and regional distribution of adiposity.
O besity is an emerging but complex risk factor for cognitive decline and dementia. Accumulating evidence from epidemiological studies suggests a link between greater adiposity at midlife and dementia. 1 In contrast, high body mass index (BMI) measured in late life has been associated with lower risk of dementia. [2] [3] [4] A well-known prodromal weight loss phenomenon preceding a diagnosis of dementia 5 has made it difficult to determine if weight loss is a result of or contributes to cognitive decline.
Another important consideration in the relationship between adiposity and cognitive decline is the regional distribution of adiposity, such as central versus overall. Increasing evidence suggests that waist circumference, a measure of central adiposity, better estimates risk of obesity-related disease than measures of overall adiposity such as BMI. 6 Obesity and late-onset dementia affect African Americans disproportionately, 7, 8 but few studies of adiposity and dementia have included substantial numbers of African Americans.
The likely modification of obesity and dementia risk by age, the potential divergent relationships of waist circumference and BMI, and the greater risk of dementia and greater prevalence of obesity in African Americans highlight the need for longitudinal studies of adiposity and cognitive function in African Americans over the adult life span. The aim of this study was to investigate the relationship between central and overall adiposity and longitudinal changes in adiposity and cognitive decline in African American adults in mid-and late life.
METHODS

Study Population
Data are from the African American cohort of the Genetic Epidemiology Network of Arteriopathy (GENOA) study, a community-based study of sibships with hypertension; although whites were recruited in GENOA, they did not have repeat measures of cognition so information on cognitive decline was not available. The GENOA study enrolled hypertensive African Americans and their siblings from Jackson, Mississippi, between 1997 and 1999 (Visit 1). At least two siblings were required to have essential hypertension before age 60; nonhypertensive siblings were also invited to participate. Detailed neurocognitive testing was conducted on the cohort concurrent with and shortly after GENOA Visit 2 (2001-06) and repeated in 2009 to 2011 (Visit 3).
Adiposity was measured for this analysis at Visits 1 and 2. Cognitive function tests were administered at Visits 2 and 3, such that the first cognitive examination coincided with the second adiposity measure. All measures used standardized protocols. Of the 1,482 African-American participants enrolled in GENOA at Visit 2, 292 were missing cognitive test results at both time-points, 40 were missing adiposity measures at Visit 2, and 31 were younger than 35. To reduce possible measurement error, 11 outliers with waist circumference measurements less than 70 cm or greater than 150 cm were excluded, resulting in 1,108 participants for the analytic cohort. The human studies institutional review board at the University of Mississippi Medical Center approved the study protocol. All participants provided informed consent.
Cognitive Outcomes
Neurocognitive tests were offered to all participants and were administered in the same sequence using standardized protocols. The test battery assessed global mental status and four cognitive domains: memory, language, processing speed, and executive function. The Mini-Mental State Examination was used to assess global cognitive function. 9 Processing speed was measured using the Wechsler Adult Intelligence Scale Revised Digit Symbol Substitution Task 10 and the Trail-Making Test Part (TMT)-A. 11 The Rey Auditory Verbal Learning Test was used to assess memory using multiple learning trials of a 15-item word list followed by 30-minute delayed recall of the word list. 11 Language was measured using the Word Fluency Test (letters F, A, and S) and the Animal Naming Task. 11, 12 The TMT-B was administered to measure executive function using time and error counts. 11 For TMT-A and B, because higher (slower) times indicate poorer performance, times were multiplied by À1 for analyses so that higher numbers represented better performance in all measures.
A composite measure was created by converting each individual test within a domain into a Z-score using the mean and standard deviation from the baseline cognitive evaluation of all participants and averaging the Z-scores as previously described. [13] [14] [15] The composite global cognitive Z-score was calculated by averaging the Z-scores of each cognitive domain and standardizing using the global Z mean and global Z standard deviation from Visit 2. Thus, a global cognitive Z-score of À1 would indicate cognitive performance that is 1 standard deviation below the global cognitive Z mean score at Visit 2.
Measures of Adiposity
Standardized protocols for adiposity measurements were followed at Visits 1 and 2. Height was measured using a stadiometer and weight using an electronic balance. BMI was calculated as weight (kilograms)/height 2 (meters). Waist circumference was measured to the nearest 0.1 cm at the umbilicus on the skin or with lightweight, nonconstricting underwear at the end of exhalation. The tape measure was held horizontal to the floor. A full-length mirror was used to verify that participants were standing erect, the tape was horizontal, and weight was equally distributed on both feet.
Waist circumference was analyzed as a continuous and a categorical variable; with tertiles categorized as 70.0 to 96.7, 96.7 to 107.7, and 107.7 to 150.0 cm.
Change in BMI and change in waist circumference were calculated as difference scores (Visit 2 measure minus Visit 1 measure) and categorized into three adiposity change groups (lost ≥5% of initial adiposity measure, gained ≥5% of initial measurement, remained stable (lost or gained less than 5% of initial measurement).
Covariates
All covariates were assessed at Visit 2. Age was categorized into two groups to distinguish between mid-(35-59) and late (≥60) life. Education was categorized as less than high school, high school, some college, or at least a college degree. Blood pressure, measured three times in a seated, rested state with appropriately sized cuffs, was defined as the average of the second and third measurements. Diagnosis of diabetes mellitus was self-reported. History of stroke was self-reported. Ever smoked was defined as having smoked more than 100 cigarettes during lifetime.
Statistical Analysis
Linear mixed models with random intercepts were used to examine the association between Visit 2 adiposity or adiposity change and longitudinal cognitive performance. The linear mixed model accounts for correlation between multiple visits and between sibships. Separate models were fit for waist circumference, BMI, change in waist circumference, and change in BMI. A two-way interaction term (adiposity and age group) was included in each model to examine differences in cognitive performance associated with adiposity between mid-and late life. After stratifying the models according to age, each model was fit with a two-way interaction term (adiposity by time) to determine whether the rate of cognitive decline differed according to adiposity. Models were adjusted for baseline age (continuous), education, sex, duration of time between measures of adiposity, and duration of time between cognitive testing. In a second model, baseline systolic blood pressure, diabetes mellitus status, history of stroke, and smoking status, which may be mediators between adiposity and cognitive performance, were further adjusted for. Table 1 for the analytical sample at Visit 2 (the first cognitive examination) and according to age group (mid-or late life). The age range was 35 to 86 (mean 58). Seventy-one percent of participants were female, and 68% had a high school degree or less, mean BMI was 31.3 kg/m 2 (obese), and according to study design, 73% had hypertension. There was an average of 5.1 years between adiposity measures and an average of 6.2 years between cognitive measures. Late-life participants had less education, smaller BMI, larger waist circumference, higher systolic blood pressure, greater prevalence of hypertension, lower baseline MiniMental State Examination scores, and a shorter duration between study visits than midlife participants. Late-life participants were also less likely to have gained more than 5% of their initial waist circumference or BMI. There were no significant differences between the mid-and late-life participants in sex distribution, smoking status, or diabetes mellitus or stroke prevalence. The annual rate of cognitive decline in late life was significantly greater (0.08 SD) than the rate in midlife (0.06 SD) (P = .002).
RESULTS
Participant characteristics are shown in
Waist Circumference
Greater waist circumference at Visit 2 was associated with greater rate of cognitive decline during follow-up (beta = À0.0009 per year, P = .001) for all participants (mid-and late life combined). The test of the interaction term between age group and waist circumference was not significant (P = .87), suggesting that age did not modify this association. Persons in the lowest waist circumference tertile had slower rates of decline than those in the middle or highest tertiles (Figure 1 , low vs high tertile: beta = 0.026, P = .001; low vs middle tertile: beta = 0.025, P = .002; middle vs high tertile: beta = 0.001, P = .88). These results were essentially unchanged after further adjustment for systolic blood pressure, diabetes mellitus status, history of stroke, and smoking history (data not shown).
The rate of cognitive decline was not significantly different among the waist circumference change groups (lost, stable, gained) in mid-life (P > .10 for the interaction term between change group and time) or in late-life (P > .10 for the interaction term between change group and time). The test of the interaction term between age group and waist circumference change group (beta = 0.17, P = .01) suggested that a loss of waist circumference in midlife was associated with a higher cognitive Z-score but a loss of waist circumference in late life was associated with a lower cognitive Zscore cognitive score (Table 2 ). In midlife, there was moderate statistical evidence of a trend of decreasing cognitive scores across the ordered levels of lost, stable, and gain in waist circumference (P = .08 for trend test). However, in late life there was a slight trend of increasing cognitive Zscores across the ordered change groups (P = .13). Pairwise comparisons between the waist circumference change groups showed no significant differences in midlife. In late life, significantly lower cognitive Z-scores were observed in the loss group than the stable group (difference in Zscores = À0.18, P = .05) and in the loss group than the gain group (difference in Z-scores = À0.21, P = .04). 297 (27) 176 (27) 121 (27) .89 Stroke, n (%) 54 (5) 28 (4) 26 (6 
Body Mass Index
BMI at Visit 2 was not significantly associated with rate of cognitive decline in mid-or late life (interaction between BMI and time: P > .10 in mid-and late life). The interaction between BMI change and age (beta = 0.17, P = .04) suggested that loss of BMI in midlife was associated with higher cognitive Z-scores in midlife but loss of BMI in late life was associated with lower cognitive Z-scores lower cognitive Zscores in late life (Table 2 ). In midlife, there was a slight association between decreasing cognitive Z-scores across the ordered levels of loss, stable, and gain in BMI (P = .11 for trend test). In contrast, there were increasing cognitive Zscores across the ordered change groups in late life (P = .14 for trend test). Pairwise comparisons between the BMI change groups in midlife showed a significantly higher mean Z-score in the stable BMI group than the gain group (difference in Z-scores = 0.13; P = .05). In late life, significantly lower cognitive Z-scores were observed in the BMI loss group than in the stable group (difference in Zscores = À0.36, P < .001) and moderately lower Z-scores in the loss group than the gain group (difference in Zscores = À0.24, P = .06).
Joint Associations Between Waist Circumference and Body Mass Index
In another set of analyses, waist circumference and BMI (obtained at Visit 2) were simultaneously included in the model to examine associations between abdominal obesity and cognitive performance while accounting for overall obesity. Table 3 shows a significant inverse relationship between waist circumference and baseline cognitive Z-score at midlife, at late life, and in the combined age groups after adjustment for BMI. In contrast, there was a weak positive association between BMI and baseline cognitive Z-score after adjustment for waist circumference.
DISCUSSION
Results from this population-based study of African Americans with prevalent cardiovascular risk factors suggest the following three key findings. First, higher central adiposity in mid-or late life was associated with a significantly greater rate of cognitive decline; neither overall adiposity nor changes in central or overall adiposity were associated with rate of decline. Second, change in adiposity (loss, stable, gain) had a divergent relationship with cognitive performance in mid-and late life such that loss (gain) of adiposity in midlife was associated with a higher (lower) cognitive Z-score, whereas loss (gain) of adiposity in late life was associated with a lower (higher) Z-score. Third, cross-sectional analysis suggested that central and overall adiposity had independent and divergent relationships with cognitive performance. Simultaneous inclusion of waist circumference and BMI measures in the model indicated an association between greater waist circumference and significantly poorer baseline cognitive performance, whereas higher BMI was associated with better baseline cognitive performance. The combination of waist circumference and BMI might be more predictive of cognitive performance than either measure alone. Studies of adiposity and cognitive outcomes in African Americans are limited and have primarily focused on overall adiposity in late life, finding a higher risk of dementia with lower adiposity. 16, 17 This is in agreement with the current results and with the well-known prodromal weight loss that precedes a diagnosis of dementia. 5, 18 Existing studies were expanded upon by contrasting relationships between overall and central adiposity and investigating changes in adiposity, as well as the joint associations between overall and central adiposity and cognitive performance in mid-and late life. The relatively short follow-up period for cognitive decline, especially in this middle-aged subcohort, accentuates the importance of these results, because longer follow-up is often required at younger ages to detect relationships with cognitive decline.
The current finding that central adiposity is associated with risk of subsequent cognitive decline is in agreement with the literature. [19] [20] [21] A potential explanation for morerobust associations between central than overall adiposity and cognitive decline includes greater relevance of central adiposity to stroke, diabetes mellitus, and cardiovascular disease, 22 which may lie on the causal pathway between obesity and cognitive decline, although adjustment for systolic blood pressure, diabetes mellitus, and stroke did not substantially abate the association between central adiposity and cognitive decline, suggesting that something inherent to central adiposity may increase the risk of cognitive decline. Adiposity and the trajectory of adiposity over the life course have been associated with brain atrophy, white matter changes, and blood-brain barrier integrity, which in turn, have been associated with greater risk of cognitive decline and late-onset dementia. [23] [24] [25] [26] [27] Other proposed candidate mediators that link adiposity and dementia are inflammatory markers and adipokines. Inflammatory markers are closely linked with adiposity and adipokines 28, 29 and are associated with poor cognitive function. [30] [31] [32] [33] [34] [35] This requires further study, particularly in African Americans, who are reported to have worse adipokine profiles than whites despite having similar adiposity levels. 36 The finding of no difference in cognitive performance between individuals in late life who gained adiposity and those whose adiposity remained stable is in agreement with the Women's Health Initiative Study of Cognitive Aging, which also reported no difference between weight and waist circumference gain and stable groups and subsequent mean levels of global or domain-specific cognitive performance during follow-up in older women. 37 One explanation could be that greater central adiposity is a risk factor for poorer cognition regardless of additional changes in central adiposity. In addition, the follow-up period may have been too short to observe substantial cognitive change.
Few studies have reported on the joint effects of central and overall adiposity on cognitive function or decline. The current findings show a positive association between overall adiposity and baseline cognitive performance and, simultaneously, a negative association between central adiposity and baseline cognitive performance in mid-and late life. This suggests that the combination of BMI and waist circumference might be more predictive of cognitive performance than either measure alone. Similar results were reported for a cohort of older Mexican Americans in a longitudinal study of cognitive impairment 20 and in the Women's Health Initiative Memory Study, in which central adiposity, defined according to waist-to-hip ratio, was associated with greater risk of cognitive impairment in normal-weight or overweight but not obese postmenopausal women. This study has several strengths, including longitudinal assessments of cognitive performance and adiposity and ascertainment of two clinically available measures of adiposity (waist circumference and BMI) in African Americans, a group with a disproportionate burden of dementia. Many participants also had cardiovascular risk factors associated with risk of dementia and cognitive decline; this may have enabled detection of relationships even in middle age. Cognitive performance was evaluated using a standard battery of cognitive tests across several domains. Potentially confounding variables and possible mediators were considered in the analyses.
38
A limitation of this study is that the GENOA study currently lacks adjudication of dementia, which restricts interpretations of these findings to cognitive function and cognitive decline as outcomes. Regardless, cognitive decline is a risk factor for incident dementia 39 and a required component of the dementia syndrome. 40 In addition it was not possible to differentiate the lean and fat components of the anthropometric measurements. Cancer, the human immunodeficiency virus, menopausal status (in women), and other conditions that can cause significant weight fluctuations may also confound the relationship between anthropometric measures and cognitive function in mid-and late life. Data were insufficient to explore the relationships between these conditions, weight change, and cognitive decline. As such, residual confounding may have affected the study results. Additionally, it was possible to measure weight and weight change only during mid-and late life, so the results may not be generalizable to adiposity and adiposity change in childhood or early adulthood. Furthermore, because the study population was African American and primarily hypertensive, these findings may not be generalizable to other populations. Nevertheless, the number of African Americans in the United States is projected to increase by more than 40% in the next few decades, with similar or larger increases in other nonwhite racial and ethnic groups, 41 many of whom are at high risk for dementia 8 and hypertension. 42 Therefore, these findings could have major public health relevance at the population level. The observational design prohibits causal inferences.
In summary, greater waist circumference, but not BMI, was associated with faster cognitive decline in midand late life, even over a relatively brief follow-up period. Loss or gain in adiposity had divergent relationships with cognitive performance in midlife and late life.
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